[PDF][PDF] 中国2 型糖尿病防治指南(2013 年版)
翁建平 - 中华糖尿病杂志, 2014 - meditool.cn
随着经济高速发展和工业化进程的加速, 生活方式的改变和老龄化进程的加速,
使我国糖尿病的患病率正呈快速上升的趋势, 成为继心脑血管疾病, 肿瘤之后另一个严重危害 …
使我国糖尿病的患病率正呈快速上升的趋势, 成为继心脑血管疾病, 肿瘤之后另一个严重危害 …
An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the Inter-Society …
TASC Steering Committee*, MR Jaff… - Journal of …, 2015 - journals.sagepub.com
The Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC)
guidelines were last updated in 2007 (TASC II) and represented the collaboration of …
guidelines were last updated in 2007 (TASC II) and represented the collaboration of …
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) The Fifth Joint Task Force of the European Society of Cardiology and …
European journal of preventive cardiology, 2012 - journals.sagepub.com
Atherosclerotic cardiovascular disease (CVD) is a chronic disorder developing insidiously
throughout life and usually progressing to an advanced stage by the time symptoms occur. It …
throughout life and usually progressing to an advanced stage by the time symptoms occur. It …
中国部分省市糖尿病足调查及医学经济学分析
王爱红， 赵湜， 李强， 王鹏华， 严励， 杜玉茗， 卞茸文… - 中华内分泌代谢 …, 2005 - cqvip.com
目的调查和分析2 型糖尿病患者糖尿病足的分类分期和医疗费用. 方法以统一的调查方法对全国
11 个省市, 14 家三级甲等医院2004 年全年门诊和住院糖尿病足患者进行调查, 包括病史回顾 …
11 个省市, 14 家三级甲等医院2004 年全年门诊和住院糖尿病足患者进行调查, 包括病史回顾 …
[PDF][PDF] 2016 European Guidelines on cardiovascular disease prevention in clinical practice
MF Piepoli, AW Hoes, S Agewall… - Polish Heart …, 2016 - journals.viamedica.pl
2.3. 9. Wnioski................................................ 838 2.4. Inne markery ryzyka.......................................
. 840 2.4. 1. Wywiad rodzinny/(epi) genetyka............ 840 2.4. 1.1. Wywiad …
. 840 2.4. 1. Wywiad rodzinny/(epi) genetyka............ 840 2.4. 1.1. Wywiad …
[HTML][HTML] ESVM Guideline on peripheral arterial disease
U Frank, S Nikol, J Belch, V Boc, M Brodmann… - Vasa, 2019 - econtent.hogrefe.com
The European Society of Vascular Medicine (ESVM) was founded in Paris in 2012 as a
confederation of already existing and emerging European societies of vascular medicine. At …
confederation of already existing and emerging European societies of vascular medicine. At …
Optimal exercise programs for patients with peripheral artery disease: a scientific statement from the American Heart Association
D Treat-Jacobson, MM McDermott, UG Bronas… - Circulation, 2019 - Am Heart Assoc
MEDLINE, MEDLINE In-Process, CINAHL, and EMBASE databases were used for the initial
literature search. The search was limited to articles published in the English language …
literature search. The search was limited to articles published in the English language …
ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert …
WS Aronow, JL Fleg, CJ Pepine, NT Artinian, G Bakris… - Circulation, 2011 - Am Heart Assoc
This document was written with the intent to be a complete reference at the time of
publication on the topic of managing hypertension in the elderly. Given the length of the …
publication on the topic of managing hypertension in the elderly. Given the length of the …
Long-term prognosis of diabetic foot patients and their limbs: amputation and death over the course of a decade
S Morbach, H Furchert, U Gröblinghoff… - Diabetes …, 2012 - Am Diabetes Assoc
OBJECTIVE There is a dearth of long-term data regarding patient and limb survival in
patients with diabetic foot ulcers (DFUs). The purpose of our study was therefore to …
patients with diabetic foot ulcers (DFUs). The purpose of our study was therefore to …
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension …
Recommendations about therapy for hypertension are here preceded by some
considerations on the strength of available evidence on the benefits associated with …
considerations on the strength of available evidence on the benefits associated with …